Loading...
XNYS
NHI
Market cap3.34bUSD
Jun 13, Last price  
70.93USD
1D
0.29%
1Q
-4.65%
Jan 2017
-3.45%
Name

National Health Investors Inc

Chart & Performance

D1W1MN
P/E
24.02
P/S
12.88
EPS
2.95
Div Yield, %
3.77%
Shrs. gr., 5y
0.18%
Rev. gr., 5y
-4.17%
Revenues
257m
-19.63%
157,382,000150,724,00062,313,00063,005,00064,221,00078,396,00082,702,00096,953,000117,828,000177,509,000228,988,000248,500,000278,659,000294,612,000318,081,000332,811,000298,715,000278,194,000319,835,000257,049,000
Net income
138m
+1.63%
54,408,00069,228,00096,435,00057,510,00064,229,00069,421,00081,132,00090,731,000106,183,000101,609,000148,862,000151,540,000159,365,000154,333,000104,157,000135,370,00062,189,00023,060,000135,654,000137,867,000
CFO
208m
+12.64%
59,010,00057,805,00066,529,00067,134,00069,212,00077,544,00076,854,00086,266,000104,193,000126,143,000164,425,000177,219,000197,325,000207,869,000240,955,000232,148,000210,859,000185,340,000184,450,000207,768,000
Dividend
Sep 27, 20240.9 USD/sh
Earnings
Aug 04, 2025

Profile

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
URL
https://www.nhireit.com/
IPO date
Jul 24, 1991
Employees
25
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
257,049
-19.63%
319,835
14.97%
278,194
-6.87%
Cost of revenue
20,736
31,334
35,111
Unusual Expense (Income)
NOPBT
236,313
288,501
243,083
NOPBT Margin
91.93%
90.20%
87.38%
Operating Taxes
(1,273)
42,441
Tax Rate
17.46%
NOPAT
237,586
288,501
200,642
Net income
137,867
1.63%
135,654
488.27%
23,060
-62.92%
Dividends
(156,510)
(156,238)
(161,771)
Dividend yield
5.12%
6.45%
6.92%
Proceeds from repurchase of equity
142,394
(151,951)
BB yield
-4.66%
6.50%
Debt
Debt current
331,200
75,425
415,408
Long-term debt
814,841
1,061,331
1,147,511
Deferred revenue
5,052
Other long-term liabilities
410,076
6,009
64,955
Net debt
1,121,752
1,114,409
1,535,195
Cash flow
Cash from operating activities
207,768
184,450
185,340
CAPEX
(3,743)
(4,629)
Cash from investing activities
(192,315)
(11,630)
197,945
Cash from financing activities
(13,568)
(169,719)
(401,254)
FCF
(198,073)
2,848,752
(305,614)
Balance
Cash
24,289
22,347
19,291
Long term investments
8,433
Excess cash
11,437
6,355
13,814
Stockholders' equity
2,614,619
2,137,134
(309,521)
Invested Capital
2,929,857
2,408,752
3,232,353
ROIC
8.90%
10.23%
6.44%
ROCE
8.03%
11.95%
8.52%
EV
Common stock shares outstanding
44,103
43,389
44,794
Price
69.30
24.08%
55.85
6.95%
52.22
-9.14%
Market cap
3,056,313
26.12%
2,423,302
3.60%
2,339,155
-10.99%
EV
4,187,855
3,557,806
4,223,667
EBITDA
307,756
358,474
313,963
EV/EBITDA
13.61
9.92
13.45
Interest
56,120
55,513
44,917
Interest/NOPBT
23.75%
19.24%
18.48%